Drug Hunter
Happy Valley, OR · Biotechnology, Other · 42 employees
Drug Hunter is the essential knowledge platform for R&D organizations turning molecules into medicines. Drug Hunter's experts keep you current by connecting the dots, distilling industry lessons from thousands of sources into a one-of-a-kind searchable platform for drug discovery knowledge you can apply to make better decisions and solve critical discovery challenges. Founded and operated by a tea
Funding history
- Funding Round — $6.0M — Sep 2025
- Series seed — Undisclosed — Sep 2025
- Series pre-seed — $698K — Mar 2024
- Series seed — $698K — Jan 2023
- Series pre-seed — $198K — Jan 2022
Recent signals
- Apr 21, 2026: Launched Drug Hunter launched Molecule Search, a unified search experience that integrates chemical and biological data for research teams.
- Sep 19, 2025: Raised $6.0M
- Sep 16, 2025: Raised funding in Series seed
- Mar 15, 2024: Raised $698K in Series pre-seed
- Jan 09, 2023: Raised $698K in Series seed
- Jan 13, 2022: Raised $198K in Series pre-seed
See plans & pricing → Track Drug Hunter’s funding, hiring, and signals — with verified contacts — on Fundz.